Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 38 of 38 entries
Sorted by: Best Match Show Resources per page
Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis.

Arthritis & rheumatology (Hoboken, N.J.)

Manfredi AA, Ramirez GA, Godino C, Capobianco A, Monno A, Franchini S, Tombetti E, Corradetti S, Distler JH, Bianchi ME, Rovere-Querini P, Maugeri N.
PMID: 34279048
Arthritis Rheumatol. 2021 Jul 19; doi: 10.1002/art.41926. Epub 2021 Jul 19.

OBJECTIVES: It is unclear why activated platelets and platelet-derived microparticles (µPs) accumulate in the blood of patients with systemic sclerosis (SSc). Here we investigated whether defective phagocytosis might contribute.METHODS: Platelet-neutrophil interaction, phagocytosis, P-selectin, PSGL-1, HMGB1 expression and distribution on...

Cite
Manfredi AA, Ramirez GA, Godino C, et al. Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis. Arthritis Rheumatol. 2021;doi: 10.1002/art.41926.
Manfredi, A. A., Ramirez, G. A., Godino, C., Capobianco, A., Monno, A., Franchini, S., Tombetti, E., Corradetti, S., Distler, J. H., Bianchi, M. E., Rovere-Querini, P., & Maugeri, N. (2021). Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis. Arthritis & rheumatology (Hoboken, N.J.), . https://doi.org/10.1002/art.41926
Manfredi, Angelo A, et al. "Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis." Arthritis & rheumatology (Hoboken, N.J.) vol. (2021). doi: https://doi.org/10.1002/art.41926
Manfredi AA, Ramirez GA, Godino C, Capobianco A, Monno A, Franchini S, Tombetti E, Corradetti S, Distler JH, Bianchi ME, Rovere-Querini P, Maugeri N. Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis. Arthritis Rheumatol. 2021 Jul 19; doi: 10.1002/art.41926. Epub 2021 Jul 19. PMID: 34279048.
Copy Download .nbib Format: NLM
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database.

Rheumatology (Oxford, England)

Gigante A, Hoffmann-Vold AM, Fegatelli DA, Gabrielli A, Leodori G, Coleiro B, De Santis M, Dagna L, Alegre-Sancho JJ, Montecucco C, Carreira PE, Balbir-Gurman A, Doria A, Riemekasten G, Airò P, Distler J, Distler O, Rosato E.
PMID: 33769468
Rheumatology (Oxford). 2021 Mar 26; doi: 10.1093/rheumatology/keab302. Epub 2021 Mar 26.

OBJECTIVES: Study aim was to evaluate estimated glomerular filtration rate (eGFR), its association with clinical disease and its predictive ability with mortality in systemic sclerosis (SSc) patients from the European Scleroderma Trials and Research Group (EUSTAR) database.METHODS: SSc patients...

Cite
Gigante A, Hoffmann-Vold AM, Fegatelli DA, et al. Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database. Rheumatology (Oxford). 2021;doi: 10.1093/rheumatology/keab302.
Gigante, A., Hoffmann-Vold, A. M., Fegatelli, D. A., Gabrielli, A., Leodori, G., Coleiro, B., De Santis, M., Dagna, L., Alegre-Sancho, J. J., Montecucco, C., Carreira, P. E., Balbir-Gurman, A., Doria, A., Riemekasten, G., Airò, P., Distler, J., Distler, O., Rosato, E. (2021). Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database. Rheumatology (Oxford, England), . https://doi.org/10.1093/rheumatology/keab302
Gigante, Antonietta, et al. "Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database." Rheumatology (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/rheumatology/keab302
Gigante A, Hoffmann-Vold AM, Fegatelli DA, Gabrielli A, Leodori G, Coleiro B, De Santis M, Dagna L, Alegre-Sancho JJ, Montecucco C, Carreira PE, Balbir-Gurman A, Doria A, Riemekasten G, Airò P, Distler J, Distler O, Rosato E. Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database. Rheumatology (Oxford). 2021 Mar 26; doi: 10.1093/rheumatology/keab302. Epub 2021 Mar 26. PMID: 33769468.
Copy Download .nbib Format: NLM
Showing 37 to 38 of 38 entries